Remedy Plan Therapeutics
Developer of medical drugs designed to halt tumor growth and prevent cancer. The company's drugs disrupt cancer stem cells by transforming the field of NAMPT inhibition with an approach that allows fo...
Valuation
$0
Share Price
N/A
Total Raised
$47.6M
Last Round
N/A